Utility of serum antibodies in determining clinical course in pediatric Crohn's disease

Clinical Gastroenterology and Hepatology

Volumn 2, Issue 2, 2004, Pages 139-146

  Desir, Barbara ^a,b   Amre, Devendra K ^a,b   Lu, Shou En ^c   Ohman Strickland, Pamela ^c   Dubinsky, Marla ^d   Fisher, Rachel ^a,b   Seidman, Ernest G ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MODEL; PEDIATRICS; PREDICTION; PROGNOSIS; QUANTITATIVE ANALYSIS; RELAPSE; SACCHAROMYCES CEREVISIAE; SCHOOL CHILD;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; CHILD; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; PROGNOSIS; SACCHAROMYCES CEREVISIAE;

EID: 0842304879     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(03)00321-5     Document Type: Article

References (31)

1. Sostegni R., Daperno M., Ercole E., Rigazio C., Bresso F., Masoero G., Castellino F., Zaffino C., Rocca R., Molinaro G.C., Rocca G., Astegiano M., Pera A. Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease is it a reliable diagnostic and prognostic marker? Dig Liver Dis. 33:2001;755-761.
2. Ruemmele F.M., Targan S.R., Levy G., Dubinsky M., Braun J., Seidman E.G. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 115:1998;822-829.
3. Duerr R.H., Targan S.R., Landers C.J., Sutherland L.R., Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis comparison with other colitidis/diarrhoeal illnesses . Gastroenterology. 100:1991;1590-1596.
4. Winter H.S., Landers C.J., Winkelstein A., Vidrich A., Targan S.R. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J Pediatr. 125:1994;707-711.
5. Dubinsky M.C., Ofman J.J., Urman M., Targan S.R., Seidman E.G. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol. 96:2001;758-765.
6. Vasiliauskas E.A., Plevy S.E., Landers C.J., Binder S.W., Ferguson D.M., Yang H., Rotter J.I., Vidrich A., Targan S.R. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology. 110:1996;1810-1819.
7. Vasiliauskas E.A., Kam L.Y., Karp L.C., Gaiennie J., Yang H., Targan S.R. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut. 47:2000;487-496.
8. Teml A., Kratzer V., Schneider B., Lochs H., Norman G.L., Gangl A., Vogelsang H., Reinisch W. Anti-Saccharomyces cerevisiae antibodies a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment . Am J Gastroenterol. 98:2003;2226-2231.
9. Satsangi J., Landers C.J., Welsh K.I., Koss K., Targan S., Jewell D.P. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm Bowel Dis. 4:1998;18-26.
10. Giaffer M.H., Clark A., Holdsworth C.D. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut. 33:1992;1071-1075.
11. Lindberg E., Magnusson K.E., Tysk C., Jarnerot G. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut. 33:1992;909-913.
12. Rump J.A., Wörner I., Roth M., Schölmerich J., Hänsch M., Peter H.H. P-ANCA of underfined specificity in ulcerative colitis correlation to disease activity and therapy . Adv Exp Med Biol. 336:1993;507-513.
13. Vermeire S., Peeters M., Vlietinck R., Joossens S., Den Hond E., Bulteel V., Bossuyt X., Geypens B., Rutgeerts P. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability a study in IBD families . Inflamm Bowel Dis. 7:2001;8-15.
14. Quinton J.-F., Sendid B., Reumaux P., Duthilleul P., Cortot A., Grandbastien B., Charrier G., Targan S.R., Colombel J.F., Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease prevalence and diagnostic role . Gut. 42:1998;788-791.
15. Linskens R.K., Mallan-Hent R.C., Anthoine Groothuismink Z.M., Bakker-Jonges L.E., van de Merwe J.P., Hooijkaas H., von Blomberg B.M., Meuwissen S.G. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods . Eur J Gastroenterol Hepatol. 14:2002;1-6.
16. Pool M.O., Ellerbroek P.M., Ridwan B.U., Goldschmeding R., von Blomberg B.M., Pena A.S., Dolman K.M., Bril H., Dekker W., Nauta J.J. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parmeters, medical, and surgical treatment. Gut. 34:1993;46-50.
17. Proujansky R., Fawcett P.T., Gibney K.M., Treem W.R., Hyams J.S. Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 17:1993;193-197.
18. Castellino F., Rosina F., Bansi D.S., Bauducci M., Touscoz G.A., Giorda L., Borghesio E., Bessone M.P., Astegiano M., Musso A. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease do they recognize different subsets of a heterogeneous disease? Eur J Gastroenterol Hepatol. 7:1995;859-864.
19. Lindgren S., Florén C.H., Lindhagen T., Starck M., Stewenius J., Nässberger L. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur J Gastroenterol Hepatol. 7:1995;563-568.
20. Bansi D.S., Chapman R.W., Fleming K.A. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 8:1996;881-885.
21. Evans C.M., Beattie R.M., Walker-Smith J.A. Inflammatory bowel disease in childhood. Allan R.N., Rhodes J.M., Hanauer S.B., Keighley M.R.B., Alexander-Williams J., Fazio V.W. Inflammatory bowel diseases. 3rd ed. 1997;647-670 Churchill Livingstone, New York.
22. Cezard J.P., Nouaili N., Talbotec C., Hugot J.P., Gobert J.G., Schmitz J., Mougenot J.F., Alberti C., Goulet O. A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (Remicade) in severe pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 36:2003;632-636.
23. Borody T.J., Leis S., Warren E.F., Surace R. Treatment of severe Crohn's disease using antimycobacterial triple therapy - approaching a cure? Dig Liver Dis. 34:2002;29-38.
24. Habtezion A., Silverberg M.S., Parkes R., Mikolainis S., Steinhart A.H. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis. 80:2002;87-92.
25. Sewitz M.J., Abrahamowicz M., Bitton A., Daly D., Wild G.E., Cohen A., Katz S., Szego P.L., Dobkin P.L. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol. 96:2001;1470-1479.
26. Rose S., Lentz J., Walsh M. Clinical evaluation of a new immunodiagnostic assay system for inflammatory bowel disease (abstr). Am J Gastroenterol. 93:1998;A597.
27. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42:1986;121-130.
28. Abreu M.T., Vasiliauskas E.A., Kam L.Y., et al. Use of serologic tests in Crohn's disease. Clin Perspectives Gastroenterol. 3:2001;155-164.
29. Roozendaal C., Pogany K., Hummel E.J., Horst G., Dijkstra G., Nelis G.F., Limburg P.C., Kleibeuker J.H., Kallenberg C.G.M. Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity. Q J Med. 92:1999;651-658.
30. Landers C.J., Cohavy O., Misra R., Yang H., Lin Y.C., Braun J., Targan S.R. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto and microbial agents. Gastroenterology. 123:2002;689-699.
31. Barůňková J., Kolářová, Šedivá A., Hölzelová E. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Clin Immunol. 102:2002;162-168.